Algo version: 0.98b
Taisho Pharmaceutical is listed at the JPX Exchange
Taisho Pharmaceutical [4581.T]
JPX Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Taisho Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Taisho Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 28th of March 2024 were paid JPY0 per share. Over the last 28 times between 2010 and 2024, Taisho Pharmaceutical has paid JPY0 with an average of JPY0 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Taisho Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY7 470.00, you would have made a profit of JPY1 120.00 per share or 14.99%

We do not have enough data to give you this answer.

Taisho Pharmaceutical has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 2.63%, which is challenging.

We have calculated the inflation risk for Taisho Pharmaceutical to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.